CRISPR Therapeutics AG CRSP
Set alert
49.99 USD -1.43 -2.78%
At close
49.82 -0.17 -0.34%
Pre-market · Nov 3, 5:04 AM ET
49.70 Day range 52.12
44.12 52-week range 64.74
- YTD
- -4.67%
- 1 year
- -19.33%
- Open
- 51.90
- Prev close
- 51.42
- Mkt cap
- 4.83B
- Vol
- 1.03M
- Avg vol
- 1.53M
- EPS
- -4.74
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 49.70
- High
- 52.12
- Forward P/E
- -14.07
- Beta
- 1.90
- Short ratio
- 9.18
- Inst. own
- 79.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 16, 2027
- 50-d avg
- 54.19
- 200-d avg
- 52.88
- 1y target
- 85.63
MAX chart
Events in this range
- May 4, 2026Earnings: -1.28; estimate -1.18964; surprise -7.6%
- Aug 3, 2026Earnings: -0.94; estimate -1.19; surprise 21.01%
- Aug 4, 2026Rating: Citigroup · Buy → Buy
- Nov 2, 2026Earnings: -1.15; estimate -1.04; surprise -10.58%
Signals (54)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 13 hours ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bearish | Mar 1, 2026 | 8 months ago |
| SMA: Bullish | Feb 1, 2026 | 9 months ago |
| SMA: Bullish | Feb 1, 2026 | 9 months ago |
| SMA: Bearish | Jan 1, 2026 | 10 months ago |
| SMA: Bearish | Jan 1, 2026 | 10 months ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jun 1, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
Newest 20 of 54.
Held by funds
115 US ETFs and mutual funds hold CRSP · largest positions
Ownership
Held by insiders 5.97%
Held by institutions 79.75%
Float held by institutions 84.80%
Institutions 680
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK Investment Management, LLC | 9.78% | 9,460,939 | 472.95M | Jun 29, 2026 |
| Blackrock Inc. | 8.63% | 8,348,977 | 417.37M | Jun 29, 2026 |
| Orbis Allan Gray Ltd | 5.64% | 5,449,161 | 272.40M | Jun 29, 2026 |
| Capital World Investors | 4.91% | 4,749,525 | 237.43M | Jun 29, 2026 |
| State Street Corporation | 4.47% | 4,321,666 | 216.04M | Jun 29, 2026 |
| GSK plc | 3.33% | 3,220,627 | 161.00M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Trust-ARK Innovation ETF | 6.79% | 6,568,594 | 328.36M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.81% | 2,716,415 | 135.79M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.41% | 2,325,509 | 116.25M | Sep 29, 2026 |
| ARK ETF Trust-ARK Genomic Revolution ETF | 2.21% | 2,133,972 | 106.68M | Sep 29, 2026 |
| NEW PERSPECTIVE FUND | 2.01% | 1,944,073 | 97.18M | Sep 29, 2026 |
| SmallCap World Fund Inc | 1.75% | 1,694,327 | 84.70M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEHBAHANI ALI | Director | Sale | Sep 16, 2026 | 16,666 |
| BRUNO JULIANNE | Chief Operating Officer | Sale | Mar 20, 2025 | 17,632 |
| GEORGE SIMEON J. | Director | Purchase | Jul 15, 2025 | 0 |
| GREENE JOHN THOMAS | Director | Purchase | Feb 25, 2025 | 7,000 |
| KASINGER JAMES R. | General Counsel | Sale | Oct 5, 2026 | 94,784 |
| KULKARNI SAMARTH | Chief Executive Officer | Sale | Oct 18, 2026 | 311,899 |